Group 4: Clinical Trials

3 trials of Group 4, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Phase 31Completed 1

Follow Group 4: new trials by email Literature Review of Group 4 trials Research Report on Group 4

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)
iCo-007 350 mcg, iCo-007 700 mcg, iCo-007 350 mcg and Laser - Diabetic Macular Edema
Phase 2TerminatedJohns Hopkins University1852012-02-012017-08-30
The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms
Placebo, Terazosine, Tolterodine - Disorder of Urinary Stent
Phase 2 / Phase 3CompletedUrmia University of Medical Sciences1042012-01-012015-03-02
A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years
Vaccine - Meningococcal Vaccine
Phase 2CompletedPfizer17142011-03-032022-10-27

Sponsors

Johns Hopkins University (1)  ·  Pfizer (1)  ·  Urmia University of Medical Sciences (1)

Countries

Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  Germany (1)  ·  Iran (1)  ·  Poland (1)  ·  Spain (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Ali Tehranchi, Urologist (1)  ·  Brian B. Berger, MD (1)  ·  David Callanan, MD (1)  ·  David M. Brown, MD (1)  ·  Dean Eliott, MD (1)  ·  Dennis M. Marcus, MD (1)  ·  Diana V. Do, MD (1)  ·  Eugene Lit, MD (1)  ·  Goergios Papastergio, MD (1)  ·  Gregg T. Kokame, MD (1)  ·  Henry L. Hudson, MD (1)  ·  Homayoun Tabandeh, MD (1)  ·  Karl G. Csaky, MD, PhD (1)  ·  Larry S. Halperin, MD (1)  ·  Louis Glazer, MD (1)

Results publications

PMID 26407272, PMID 32681472, PMID 35164991

NIH funding

2009 (1)